毒动力学-毒动力学建模揭示了不同尺寸的聚乙烯纳米塑料的生态风险
Ke-Da Zhang1, Zhen Wang2, Hong-Jie Zhang1
1State Key Laboratory of Water Pollution Control and Green Resource Recycling, School of the Environment, Nanjing University, Nanjing, Jiangsu Province, 210023, China.
Environmental pollution (Barking, Essex : 1987)
|July 10, 2025
概括
纳米塑料 (NP) 构成生态风险,但安全门尚不清楚. 这项研究使用毒动力学-毒动力学 (TK-TD) 模型来评估多聚烯纳米塑料 (PS NP) 生物积累和大的毒性,揭示了取决于大小的效应,并为风险评估提供了关键数据.
科学领域:
- 环境科学 环境科学
- 生态毒理学 生态毒理学
- 纳米技术 纳米技术
背景情况:
- 水生生态系统中的纳米塑料 (NP) 存在重大生态风险.
- 对NP的环境安全门定义不佳,阻碍了准确的风险评估.
- 了解NP生物积累和毒性对于保护水生生物至关重要.
研究的目的:
- 为了研究多纳米塑料 (PSNP) 在大的生物积累和毒性不同大小.
- 为预测NP毒性建立一个毒动力学-毒动力学 (TK-TD) 建模框架.
- 确定不同的PS NP大小的环境安全门,包括LC50和无效度.
主要方法:
- 采用了毒动力学-毒动力学 (TK-TD) 建模框架.
- 使用聚合诱导排放素标记PSNP用于精确的生物积累跟踪.
- 进行光成像,转录基因分析和毒性评估 (LC50,无效度).
主要成果:
- 较小的PS NPs在胸部附属物中积累,并表现出更高的毒性,破坏消化并引起氧化应激.
- 较大的PSNP主要积聚在肠道中,吸收和排泄率通常随大小而增加.
- TK-TD模型预测了不同PS NP大小 (30-200纳米) 的48小时LC50和无效度的变化.
结论:
- 该研究建立了一个强大的TK-TD框架,用于在受控条件下预测PS NP毒性.
- 这些发现突出了大小依赖的生物积累和PSNP在Daphnia magna中的毒性.
- 为未来对水生生态系统中纳米塑料的环境风险评估提供必要的基础数据.
相关概念视频
Types of Toxins
2.0K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
2.0K
Pharmacokinetic Models: Overview
1.2K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.2K
Pharmacokinetic Models: Comparison and Selection Criterion
153
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
153
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
130
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
130


